Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1998-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.18.9.1417PMID 9743230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.

  1997cited by this paper
• Apolipoprotein A-I Structural Modification and the Functionality of Reconstituted High Density Lipoprotein Particles in Cellular Cholesterol Efflux*

  1996cited by this paper
• Functional Lecithin:Cholesterol Acyltransferase Deficiency and High Density Lipoprotein Deficiency in Transgenic Mice Overexpressing Human Apolipoprotein A-II (*)

  1996cited by this paper
• Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.

  1996cited by this paper
• Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*)

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*)

  1995cited by this paper
• Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

  1995cited by this paper
• The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.

  1994cited by this paper
• A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.

  1994cited by this paper
• Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.

  1993cited by this paper
• Cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein A-I (LpA-I) increases with particle size but cholesterol transfer from LpA-I to lipoproteins decreases with size.

  1993cited by this paper
• Protein composition determines the anti-atherogenic properties of HDL in transgenic mice

  1993cited by this paper
• Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway.

  1992cited by this paper
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.

  1992cited by this paper
• α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux

  1992cited by this paper
• Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.

  1992cited by this paper
• Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs.

  1992cited by this paper
• Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages.

  1991cited by this paper
• Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

  1991cited by this paper
• Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol.

  1991cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper
• Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

  1988cited by this paper
• Apolipoprotein A-I containing lipoproteins in coronary artery disease.

  1987cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper
• Nondenaturing polyacrylamide gradient gel electrophoresis.

  1986cited by this paper
• Plasma lipoproteins: apolipoprotein structure and function.

  1984cited by this paper
• Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase.

  1981cited by this paper
• Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents.

  1980cited by this paper
• A new enzymatic method for determination of serum choline-containing phospholipids.

  1977cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• The plasma lecithins:cholesterol acyltransferase reaction.

  1968cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• Apolipoprotein A (ApoA) in Neurological Disorders: Connections and Insights

  2025cites this paper
• HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals.

  2024cites this paper
• Microarray analysis identifies human apoA-IMilano and apoA-II as determinants of the liver gene expression related to lipid and energy metabolism.

  2023cites this paper
• High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives

  2021cites this paper
• New Strategies to Promote Macrophage Cholesterol Efflux

  2021cites this paper
• A personalised diet study: The interaction between ApoA2 −265T > C polymorphism and dietary inflammatory index on oxidative and inflammatory markers and lipid profile in patients with type 2 diabetes mellitus: A cross‐sectional study

  2021cites this paper
• ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease[S]

  2019cites this paper
• Change of HDL by Life Style

  2019cites this paper
• A Compendium of the Biological Effects of Apolipoprotein A-IMilano

  2019cites this paper
• APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe-/- atherosclerotic mice.

  2018cites this paper
• Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats

  2018cites this paper
• High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology: A structural and ultrastructural study.

  2015cites this paper
• Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice

  2015cites this paper
• Evaluating the association of APOA2 polymorphism with insulin resistance in adolescents

  2014cites this paper
• Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats.

  2013cites this paper
• APOA2 Polymorphism in Relation to Obesity and Lipid Metabolism

  2013cites this paper
• Genetic Determination of Plasma Cholesterol Efflux Capacity Is Gender-Specific and Independent of HDL-Cholesterol Levels

  2013cites this paper
• Cholesterol-lowering effect of dietary Lupinus angustifolius proteins in adult rats through regulation of genes involved in cholesterol homeostasis.

  2012cites this paper
• Rosuvastatin does not affect human apolipoprotein A‐I expression in genetically modified mice: a clue to the disputed effect of statins on HDL

  2011cites this paper
• Hypolipidemic effect of dietary pea proteins: Impact on genes regulating hepatic lipid metabolism.

  2010cites this paper
• Long Pentraxin 3, a Key Component of Innate Immunity, Is Modulated by High-Density Lipoproteins in Endothelial Cells

  2008cites this paper
• Avaluació del Transport Revers de Colesterol Específic de Macròfags

  2008cites this paper
• QUE INTERVENEN A L'ESTRUCTURA I METABOLISME DE L'HDL: APOA-II, CETP, ABCA-1 I ABCG5-G8

  2008cites this paper
• Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients.

  2007cites this paper
• Regulation of human hepatocyte gene expression by fatty acids.

  2007cites this paper
• Molecular markers of obesity and diabetes

  2007cites this paper
• A Caucasian male with very low blood cholesterol and low apoA‐II without evidence of atherosclerosis

  2007cites this paper
• Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice.

  2006cites this paper
• Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study

  2006cites this paper
• Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects

  2006cites this paper
• L. Catapano Expression in 2 Β High-density Lipoproteins Induce Transforming Growth Factor- High-density Lipoproteins Induce Transforming Growth Factor-␤ 2 Expression in Endothelial Cells

  2005cites this paper
• Small high density lipoprotein subclasses: some of their physico-chemical properties and stability in solution.

  2005cites this paper
• High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.

  2005cites this paper
• Expression analysis of a human hepatic cell line in response to palmitate.

  2005cites this paper
• High-Density Lipoproteins Induce Transforming Growth Factor- (cid:1) 2 Expression in Endothelial Cells

  2005cites this paper
• The Use of Animal Models to Study Diabetes and Atherosclerosis and Potential Anti-Atherosclerotic Therapies

  2005cites this paper
• High-Density Lipoproteins Induce Transforming Growth Factor-&bgr;2 Expression in Endothelial Cells

  2005cites this paper
• Efecte del tractament amb difenilhidantoïna sobre el perfil lipoproteic i la susceptibilitat a l'arteriosclerosi en models murídics

  2004cites this paper
• Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance

  2003cites this paper
• Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I*

  2003cites this paper
• Identification and expression of scavenger receptor SR-BI in endothelial cells and smooth muscle cells of rat aorta in vitro and in vivo.

  2002cites this paper
• Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux

  2002cites this paper
• Molecular Characterization of the T(4;9)12Gso Mutation and Analysis of the Associated Fitness, Skeletal, and Lymphoproliferative Phenotypes

  2002cites this paper
• Opposite Effects of Plasma From Human ApoA-II Transgenic Mice on Cholesterol Efflux From J 774 Macrophages and Fu 5 AH Hepatoma Cells

  2002cites this paper
• Opposite Effects of Plasma From Human Apolipoprotein A-II Transgenic Mice on Cholesterol Efflux From J774 Macrophages and Fu5AH Hepatoma Cells

  2002cites this paper
• Apolipoprotein A-II, HDL metabolism and atherosclerosis.

  2002cites this paper
• Apolipoproteins and β Amyloid Transport Pathway

  2002cites this paper
• Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I

  2001cites this paper
• Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.

  2001cites this paper
• [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].

  2001cites this paper
• Structural studies of discoidal lipoprotein A-I

  2001cites this paper
• Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II

  2001cites this paper
• Animal Models of Diabetes and Atherosclerosis

  2001cites this paper
• Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.

  2000cites this paper
• Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum.

  2000cites this paper
• Cell cholesterol efflux: integration of old and new observations provides new insights.

  1999cites this paper
• Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice.

  1999cites this paper
• High-density lipoprotein subclasses and apolipoprotein A-I.

  1999cites this paper
• Oxidized low density lipoprotein causes impaired efflux of cholesterol from macrophages : implications for atherogenesis

  1999cites this paper
• Genetics and molecular biology Structure and function of apolipoprotein A-I and high-density lipoprotein Review: (pp. 105±115)

  year unknowncites this paper